Sentence examples for iv mortality from inspiring English sources

APACHE III and APACHE IV mortality have excellent discrimination but poor calibration.

Accuracies of SAPS III and APACHE IV mortality predicted risk were assessed by calculating the area under the receiver operating characteristic curve.

Among patients in PSI category IV, mortality remained minimal until D-dimer levels exceeded 2,000 ng/ml, at which point the death rate was 10%.

A prospective collection of data concerning APACHE II and APACHE III, and a retrospective analysis of complimentary data necessary for APACHE IV mortality calculation.

The following variables were evaluated as possible risk factors for readmission: sex, age, type of admission (medical vs. surgical), SAPS III, APACHE III score, APACHE IV mortality predicted risk, ICU length of stay (LOS), ICU discharge at night and on weekends.

We developed a series of multivariable regression models to examine independent associates of: (i) psychological distress (K-10 score); (ii) non-adherence to anti-TB treatment; (iii) improvement in morbidity after six months of treatment; (iv) mortality; (v) cough duration prior to seeking care; and (vi) whether patients reported at follow-up their employment had been affected by their TB.

Patients with diabetes were older, had higher APS scores and APACHE IV predicted mortality, and higher mortality than did patients without diabetes.

Patients who developed infection had significantly longer ICU length of stay (P < 0.0001), higher scores for severity of illness (mean APACHE IV predicted mortality 34.8% vs. 18.5%, P < 0.0001) and greater mortality (32.4% vs. 13.3%, P < 0.0001) than did those who did not develop infection.

Cardiovascular surgery patients did not have APACHE IV predicted mortality calculated.

The APACHE IV predicted mortality and length of stay equations perform well in a subset of patients with acute renal failure in our population.

However, the comparison group was almost entirely composed of WHO stage III patients, which would weaken the statistical effect of WHO stage IV on mortality.